Dr. Denise Scots-Knight
Chief Executive Officer
We are led by a highly passionate senior management team with established track record in late-stage clinical development, and extensive experience in pharmaceutical and biotechnology companies.
Christine Fox
Chief Financial Officer
Charles Sermon
General Counsel and Business Development
John Richard
Business and Corporate Development
Dr. John Lewicki
Chief Scientific Officer
Dr. Jackie Parkin
SVP and Therapeutic Head
Wills Hughes-Wilson
Chief Patient Access and Commercial Planning